Fact CheckerSign in

NCT05435963Completed

Impact of Pulmonary Rehabilitation on Loneliness in COPD

Effect of Pulmonary Rehabilitation on Reducing Loneliness in Individuals With Chronic Obstructive Pulmonary Disease (COPD)

Source: ClinicalTrials.gov · Last updated 23 May 2025

Brief summary (registry, in English)

Loneliness is the feeling of sadness because one wants friends or company. This feeling is common in patients with chronic lung disease, who suffer from breathing difficulty, chronic cough, and reduced physical and mental health. These problems lead to a reduced ability for doing daily activities and cause a loss of social life. Pulmonary rehabilitation (PR) includes exercise and education. PR has been shown to improve health status in patients with chronic lung disease but its impact on loneliness levels has never been assessed. This study aims to assess the effect of PR on reducing loneliness in patients with chronic lung disease.

Status (registry)
Completed
Study type
Interventional
Enrollment
45 (actual)
First submitted
22 Jun 2022
Start date
23 Jan 2023
Primary completion date
31 Oct 2023
Lead sponsor
McMaster University
Diseases
COPD
NCT number
NCT05435963

What you commit to

  • Study type: Interventional
  • Participants enrolled: 45
  • From 23 Jan 2023 to the primary completion date, 31 Oct 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other

  • Do not have sufficient language skills (non-English speaking or reduced cognition)
  • Are unable to complete at least 60% of PR
  • Fail to complete the primary outcome measure, the University of California, and Los Angeles Loneliness scale (UCLA-LS).

Who the study is looking for

  • A spirometry (FEV1/FVC \< 0.70) or physician-confirmed diagnosis of COPD
  • Aged 18 years or more
  • Ability to complete at least 60% of the PR program that includes exercise, education, and behaviour change intervention
  • Ability to provide written informed consent.
    • Abbreviations:
    • FEV1: forced expiratory volume in 1 second FVC: forced vital capacity

Age in the registry: 18 years to 100 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
West Park Healthcare Centre
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.